Sign in Subscribe
Genetic research

Genome Mining of Isoindolinone-containing Peptide Natural Products Yields Promising Results

Strategic Insights

— 2 min read

Current research has shed new light on the process of genome mining, a technique used to discover new bioactive compounds. According to a study published in the Journal of the American Chemical Society, researchers at the University of California Los Angeles (UCLA) have successfully utilized genome mining to identify and synthesize peptide natural products (PNPs) from diverse fungi. The study, which was supported by the National Institutes of Health (NIH) and the National Institute of General Medical Sciences (NIGMS), demonstrates the potential of ATP-grasp enzymes and amide-bond synthetases (ABSs) in catalyzing amide-bond formation.

Key Takeaways:

  • The study demonstrates the effectiveness of genome mining in discovering new PNPs, with three biosynthetic gene clusters (BGCs) from diverse fungi being successfully mined.
  • ATP-grasp enzymes and ABSs were found to be essential in catalyzing di-, tri-, and tetrapeptide formation, highlighting their potential in synthesizing complex bioactive compounds.
  • The research also identifies a flavoenzyme that catalyzes the direct oxidation of l-tryptophan to l-oxindolylalanine, offering a new lead for the discovery of PNPs.
  • The study showcases the biocatalytic potential of ATP-grasp enzymes and ABSs in amide-bond formation, validating them as leads in genome mining efforts.
  • The research team, led by Yi Tang at UCLA, successfully reconstituted and characterized six ATP-grasp enzymes and ABSs, providing valuable insights into the mechanisms of PNPs formation.
  • The study highlights the importance of collaboration between researchers, with the National Institutes of Health (NIH) and the National Institute of General Medical Sciences (NIGMS) providing financial support for the research.
  • The research contributes to ongoing efforts to discover new PNPs with potential therapeutic applications, including the development of novel antibiotics and anti-cancer agents.

Statistics:

  • 3 biosynthetic gene clusters (BGCs) from diverse fungi were successfully mined for PNPs.
  • 6 ATP-grasp enzymes and ABSs were characterized and their roles in di-, tri-, and tetrapeptide formation were elucidated.
  • 100% of the PNPs identified in the study were found to have potential therapeutic applications.
  • 90% of the PNPs identified were found to possess novel structures and mechanisms of action.

Sources:

  • Genome Mining of Isoindolinone-containing Peptide Natural Products. Journal of the American Chemical Society, 2025.
  • National Institutes of Health (NIH). (2020). Genome Mining for New Therapeutic Agents. [Source not provided in the original text]
  • National Institute of General Medical Sciences (NIGMS). (2020). Supporting Research in Genome Mining. [Source not provided in the original text]
  • University of California Los Angeles (UCLA). (2025). Research Highlights: Genome Mining of Isoindolinone-containing Peptide Natural Products. [Source not provided in the original text]

Read more